ALB and nutritional deficiency disease: The advantage of the marker is its ease of availability and low cost allowing easy risk stratification of patients even in lower-income countries.16 The potential role of RDW as a biomarker has been attributed to its ability to reflect systemic inflammation.9-15 To further improve its prognostic ability, it has been recently combined with albumin, another marker of inflammation and malnutrition.17 The RDW-albumin ratio (RAR) has also been used to predict the prognosis of several illnesses.17,18 However, their value in predicting complications of T2DM is still underexplored.